Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetics and Therapeutic Drug Monitoring for the Optimization of Fluoropyrimidine Treatment in Patients With Advanced Colorectal Cancer

NCT01641458 is registered in ClinicalTrials.gov with Cantonal Hospital of St. Gallen as lead sponsor.

NCT NCT01641458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01641458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetics and Therapeutic Drug Monitoring for the Optimization of Fluoropyrimidine Treatment in Patients With Advanced Colorectal Cancer
Lead sponsor
Cantonal Hospital of St. Gallen
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2012
Completion date
November 30, 2015
Enrollment
37 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer